Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18735109 | 1.00 | CYP2C9 (0.34) | CYP2C9MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18735396 | 0.92 | SMN1; SMN2 (0.33) | CYP2C9MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18735395 | 0.92 | SMN1; SMN2 (0.33) | CYP2C9MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL17164978 | 0.92 | CYP2C9 (0.33) | CYP2C9MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL18735186 | 0.90 | CYP2C9 (0.30) | CYP2C9 | |
| SCHEMBL18735142 | 0.87 | KMT2A (0.39) | CYP2C9KMT2A | |
| SCHEMBL18734934 | 0.87 | — | — | |
| SCHEMBL18735180 | 0.86 | ALOX15 (0.32) | — | |
| SCHEMBL18734935 | 0.85 | KMT2A (0.32) | KMT2A | |
| SCHEMBL18734926 | 0.84 | ALOX15 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017060400-A1 | PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS | NEUROVIVE PHARMACEUTICAL AB (SE) | 2017-04-13 | — | — | WO | disclosed |